Skip to content

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01211652
Enrollment
8186
Registered
2010-09-29
Start date
2010-10-31
Completion date
2010-11-30
Last updated
2013-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Compliance, France, Self-administered questionnaire to patients

Brief summary

The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* French people \> 65 years old, part of Kantar Health Access Santé panel

Design outcomes

Primary

MeasureTime frame
NSAID Treatment ComplianceAt the end of month 1
Gastroprotective agent compliance (Girerd Questionnaire)At the end of month 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026